Abdominal Stent Graft System Market Report
Published Date: 21 April 2026 | Report Code: abdominal-stent-graft-system
Abdominal Stent Graft System Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Abdominal Stent Graft System market, detailing current trends, market size, and forecasts from 2023 to 2033. Key insights regarding regional performances and advancements in technology are also included.
Key Takeaways
- Global valuation reached $2.50 Billion in 2023, with projected rise to $4.91 Billion by 2033 at a 6.8% CAGR.
- North America is both the largest market and the fastest-growing region, reflecting strong adoption and investment in endovascular care.
- Endovascular stents, delivery systems and accessories remain the primary product groups shaping demand.
- Hospitals and ambulatory surgical centers drive device usage, supported by minimally invasive procedure preferences.
- Leading firms—Medtronic, Abbott Laboratories, Boston Scientific, Cook Medical and Terumo Corporation—dominate innovation and distribution.
Abdominal Stent Graft System Market Report — Executive Summary
The market for abdominal stent graft systems is expanding steadily, driven by demographic shifts and procedural preference toward less invasive vascular interventions. Valued at $2.50 Billion in 2023 and forecast to reach $4.91 Billion by 2033 at a 6.8% CAGR, the market structure includes product types such as endovascular stents, delivery systems and accessories, alongside material and application categories. Regional analysis highlights North America as the foremost market and fastest-growing region, supported by advanced healthcare infrastructure and adoption of new technologies. Key applications include aneurysm repair and stenosis treatment, with hospitals and ambulatory surgical centers representing principal end users. Competition centers on product refinement, delivery accuracy and biocompatible materials; Medtronic, Abbott Laboratories, Boston Scientific, Cook Medical and Terumo Corporation are profiled for market presence and strategic activity. The report outlines segment-level opportunity areas and risk factors such as regulatory pathways and material cost variability.
Key Growth Drivers
- Rising incidence of vascular conditions and an aging population increasing demand for durable stent graft solutions.
- Shift toward minimally invasive procedures that shorten recovery times and expand outpatient treatment volumes.
- Ongoing device innovation focused on biocompatible materials and improved delivery systems enhancing clinical outcomes.
- Regulatory and reimbursement environments in developed regions supporting adoption and clinical trials.
- Consolidation and strategic partnerships among leading manufacturers accelerating product availability and geographic reach.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | Medtronic , Abbott Laboratories, Boston Scientific, Cook Medical, Terumo Corporation |
| Last Modified Date | 21 April 2026 |
Abdominal Stent Graft System Market Overview
Customize Abdominal Stent Graft System Market Report market research report
- ✔ Get in-depth analysis of Abdominal Stent Graft System market size, growth, and forecasts.
- ✔ Understand Abdominal Stent Graft System's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Abdominal Stent Graft System
What is the Market Size & CAGR of Abdominal Stent Graft System Market Report market in 2023?
Abdominal Stent Graft System Industry Analysis
Abdominal Stent Graft System Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Abdominal Stent Graft System Market Report Market Analysis Report by Region
Europe Abdominal Stent Graft System Market Report:
Europe grows from $0.76 Billion in 2023 to $1.5 Billion in 2033. Expansion is supported by growing awareness of vascular disease management, established hospital networks and steady uptake of improved stent graft platforms.Asia Pacific Abdominal Stent Graft System Market Report:
Asia Pacific increases from $0.51 Billion in 2023 to $1.01 Billion in 2033. Market momentum is driven by expanding healthcare access, growing procedural capacity and rising demand for less invasive vascular treatments.North America Abdominal Stent Graft System Market Report:
North America is the largest and fastest-growing region, rising from $0.82 Billion in 2023 to $1.61 Billion in 2033. Advanced clinical adoption, strong procedural volumes and investment in minimally invasive technologies propel regional leadership and rapid expansion.South America Abdominal Stent Graft System Market Report:
Middle East & Africa Abdominal Stent Graft System Market Report:
Middle East and Africa expands from $0.32 Billion in 2023 to $0.62 Billion in 2033. Improvements in clinical infrastructure and a growing focus on population health contribute to adoption of endovascular stent graft solutions.Tell us your focus area and get a customized research report.
Research Methodology
Abdominal Stent Graft System Market Analysis By Product
The market for abdominal stent graft systems by product type includes endovascular stents, delivery systems, and accessories. Endovascular stents dominate the market in terms of size, accounting for $1.61 billion in 2023 and projected to reach $3.16 billion by 2033. Delivery systems follow with $0.51 billion in 2023, growing to $0.99 billion by 2033. Accessories, while smaller, hold importance in comprehensive treatment protocols.
Abdominal Stent Graft System Market Analysis By Application
The application segmentation includes aneurysm repair and stenosis treatment. Aneurysm repair accounts for a significant market share, valued at $1.61 billion with a consistent growth trajectory. Stenosis treatment, although smaller, is also projected to grow from $0.51 billion to $0.99 billion by 2033, reflecting increased demand for therapeutic interventions.
Abdominal Stent Graft System Market Analysis By End User
End-users comprise hospitals, ambulatory surgical centers, and other surgical facilities, with hospitals capturing the largest share. In 2023, hospitals accounted for approximately $1.61 billion, expected to grow to $3.16 billion by 2033. Ambulatory surgical centers are also significant, growing from $0.51 billion to $0.99 billion over the same period.
Abdominal Stent Graft System Market Analysis By Material
The primary materials used in stent graft systems include nitinol, polymer, and other materials. Nitinol leads the market with $1.61 billion (2023) and is anticipated to double in size by 2033. Polymer-based systems are gaining traction, moving from $0.51 billion to $0.99 billion, reflecting innovation in biocompatibility.
Abdominal Stent Graft System Market Analysis By Region
The regional market analysis highlights North America as the largest market but shows significant growth potential in Asia Pacific and Africa, where growing healthcare challenges necessitate innovation and investment. The competitive landscape varies greatly by region, influenced by regulatory environments and healthcare access.
Abdominal Stent Graft System Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Abdominal Stent Graft System Industry
Medtronic :
A leading global developer of medical devices, Medtronic offers a comprehensive range of abdominal stent grafts known for their reliability and efficacy.Abbott Laboratories:
Abbott is recognized for its cutting-edge vascular technologies and consistently introduces innovative solutions for treating abdominal diseases.Boston Scientific:
Boston Scientific focuses on advanced endovascular stent graft systems and is pivotal in driving innovation in the minimally invasive surgical space.Cook Medical:
Cook Medical specializes in minimally invasive medical devices and offers a diverse portfolio in abdominal stent graft systems, focusing on customization and adaptability.Terumo Corporation:
Terumo is committed to improving patient outcomes through innovative vascular solutions and plays a key role in the abdominal stent graft market.We're grateful to work with incredible clients.
FAQs
What is the market size of the abdominal stent graft system in 2023?
The market size was $2.50 Billion in 2023. Forecasts indicate growth to $4.91 Billion by 2033, reflecting a 6.8% compound annual growth rate across the 2023 to 2033 forecast period.
How big will the market be by 2033?
By 2033 the market is projected to reach $4.91 Billion. This projection reflects sustained expansion over the 2023 to 2033 period driven by procedure adoption and technological enhancements.
What is CAGR for the forecast period?
The market is expected to grow at a 6.8% CAGR during the 2023 to 2033 forecast window, signaling steady compound growth driven by clinical demand and product development.
Why is North America significant for this market?
North America is the largest and fastest-growing region, supported by advanced healthcare infrastructure, high procedural volumes and early uptake of innovations in stent graft design and delivery systems.
Which product categories lead market segmentation?
Primary product groups include endovascular stents, delivery systems and accessories. These categories collectively account for the core procedural components used in aneurysm repair and related vascular interventions.
Who are the top companies in this market?
Leading participants named in the report include Medtronic, Abbott Laboratories, Boston Scientific, Cook Medical and Terumo Corporation, noted for product portfolios and market reach.
What drives demand in hospital and outpatient settings?
Hospitals and ambulatory surgical centers drive demand due to procedural volume, clinician preference for minimally invasive approaches, and infrastructure that supports endovascular interventions.
How big is the Europe market in 2023?
Europe recorded a market size of $0.76 Billion in 2023 and is expected to grow to $1.5 Billion by 2033, reflecting adoption of minimally invasive vascular treatments across the region.
Why are material innovations important?
Material advances such as improved nitinol alloys and polymers enhance device flexibility, durability and biocompatibility, supporting better clinical performance and broader procedural applicability.
Which end users are covered in segmentation?
Key end-user segments include hospitals, ambulatory surgical centers and other end users, representing the primary settings where abdominal stent graft systems are deployed.